In addition, p38 MAPK activity was shown to be inhibited in all NRAS-mutant melanoma cell lines following corin treatment (Figure 10C), with associated increases in DUSP1 and DUSP5 expression (Figure 10D). The gene discussed is DUSP5; the disease is melanoma.